Condensed Statements of Changes in Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024		60,094,083
Beginning balance at Dec. 31, 2024	$ 181,816	$ 6	$ 506,985	$ (325,127)	$ (48)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units, net of shares withheld for taxes (in shares)		446,756
Vesting of restricted stock units, net of shares withheld for taxes	(73)		(73)
Stock options exercised for cash (in shares)		32,586
Stock options exercised for cash	37		37
Unrealized (loss) gain on marketable securities	63				63
Stock-based compensation	2,474		2,474
Net loss	(28,796)			(28,796)
Ending balance (in shares) at Mar. 31, 2025		60,573,425
Ending balance at Mar. 31, 2025	$ 155,521	$ 6	509,423	(353,923)	15
Beginning balance (in shares) at Dec. 31, 2025	60,575,369	60,575,369
Beginning balance at Dec. 31, 2025	$ 70,430	$ 6	516,803	(446,462)	83
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Private placement issuance of common stock, net of offering costs (in shares)		10,833,331
Private placement issuance of common stock, net of offering costs	35,453	$ 1	35,452
Vesting of restricted stock units, net of shares withheld for taxes (in shares)		727,052
Vesting of restricted stock units, net of shares withheld for taxes	$ (149)		(149)
Stock options exercised for cash (in shares)	91,828	91,828
Stock options exercised for cash	$ 145		145
Unrealized (loss) gain on marketable securities	(62)				(62)
Stock-based compensation	2,396		2,396
Net loss	$ (20,737)			(20,737)
Ending balance (in shares) at Mar. 31, 2026	72,227,580	72,227,580
Ending balance at Mar. 31, 2026	$ 87,476	$ 7	$ 554,647	$ (467,199)	$ 21